GGrantIndex
← Leaderboards

Bruce S Kristal

Winifred Masterson Burke Med Res Inst

$21,689,678
Attributed
$21,689,678
Total exposure
13
Grants
10
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).

Funding over time

peak $1.8M · FY200521
$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21

Funding mix

By agency

NIH$21,689,678 · 13

By mechanism

R01$15,183,578 · 8
P01$3,304,526 · 2
U01$1,899,753 · 1
RC1$998,679 · 1
R21$303,142 · 1

Top collaborators

No co-investigators on record.

Most similar at Winifred Masterson Burke Med Res Inst

Same institution · by research overlap

Others in their field

Top investigators on “Diet

Research focus

DietLinkBaseDisorder RiskCase ControlSamplingMetabolomicsFuturePlasmaBioinformaticsMetabolicUnited States National Institutes Of HealthRattusFeedingEnergy IntakeEpidemiologyPattern RecognitionObesityBiological MarkersDetectionResourcesInterestHealth StudyFatty Acid Glycerol Esters

Grant awards (46)

Lipidomics Biomarkers Link Sleep Restriction to Adiposity Phenotype, Diabetes, and Cardiovascular Risk$850,665
R01 · FY2021 · HL · contact PI
Lipidomics Biomarkers Link Sleep Restriction to Adiposity Phenotype, Diabetes, and Cardiovascular Risk$856,469
R01 · FY2020 · HL · contact PI
Circadian Lipidomics in Constant Routine, Forced Desynchrony, and Non-lab Setting$862,336
R01 · FY2019 · HL · contact PI
Lipidomics Biomarkers Link Sleep Restriction to Adiposity Phenotype, Diabetes, and Cardiovascular Risk$861,753
R01 · FY2019 · HL · contact PI
Lipidomics Biomarkers Link Sleep Restriction to Adiposity Phenotype, Diabetes, and Cardiovascular Risk$873,305
R01 · FY2018 · HL · contact PI
Circadian Lipidomics in Constant Routine, Forced Desynchrony, and Non-lab Setting$863,172
R01 · FY2018 · HL · contact PI
Circadian Lipidomics in Constant Routine, Forced Desynchrony, and Non-lab Setting$877,276
R01 · FY2017 · HL · contact PI
Circadian Lipidomics in Constant Routine, Forced Desynchrony, and Non-lab Setting$848,973
R01 · FY2016 · HL · contact PI
Associations of Metabolomic Predictors of Fat Amount and Distribution with Ca$627,534
P01 · FY2016 · CA · contact PI
Associations of Metabolomic Predictors of Fat Amount and Distribution with Ca$642,119
P01 · FY2015 · CA · contact PI
BiospecimenIntegrity: Assessing Quality and Influence on -Omics-based Analyses$439,556
R01 · FY2015 · HL · contact PI
Associations of Metabolomic Predictors of Fat Amount and Distribution with Ca$613,551
P01 · FY2014 · CA · contact PI
BiospecimenIntegrity: Assessing Quality and Influence on -Omics-based Analyses$437,325
R01 · FY2014 · HL · contact PI
High Resolution Plasma Lipidomics in CALERIE$176,917
R01 · FY2014 · AG · contact PI
Associations of Metabolomic Predictors of Fat Amount and Distribution with Ca$595,346
P01 · FY2013 · CA · contact PI
BiospecimenIntegrity: Assessing Quality and Influence on -Omics-based Analyses$424,830
R01 · FY2013 · HL · contact PI
High Resolution Plasma Lipidomics in CALERIE$352,833
R01 · FY2013 · AG · contact PI
Associations of Metabolomic Predictors of Fat Amount and Distribution with Ca$644,770
P01 · FY2012 · CA · contact PI
BiospecimenIntegrity: Assessing Quality and Influence on -Omics-based Analyses$416,510
R01 · FY2012 · HL · contact PI
Validated Biomarkers for Primary Macronutrient Balance$498,679
RC1 · FY2010 · ES · contact PI
Macronutrients, Mitochondria and Blood Metabolome/Proteome Disease Risk Profiles$431,098
U01 · FY2010 · ES · contact PI
Serum Metabolomic/Proteomic Profiles in CALERIE$335,846
R01 · FY2010 · AG · contact PI
Macronutrients, Mitochondria and Blood Metabolome/Proteome Disease Risk Profiles$161,820
U01 · FY2010 · ES · contact PI
Caloric Restriction Biomarkers Predict Type II Diabetes?$504,541
R01 · FY2009 · AG · contact PI
Validated Biomarkers for Primary Macronutrient Balance$500,000
RC1 · FY2009 · ES · contact PI
Macronutrients, Mitochondria and Blood Metabolome/Proteome Disease Risk Profiles$423,246
U01 · FY2009 · ES · contact PI
Serum Metabolomic/Proteomic Profiles in CALERIE$339,300
R01 · FY2009 · AG · contact PI
Caloric Restriction Biomarkers Predict Type II Diabetes?$499,333
R01 · FY2008 · AG · contact PI
Macronutrients, Mitochondria and Blood Metabolome/Proteome Disease Risk Profiles$425,963
U01 · FY2008 · ES · contact PI
Serum Metabolomic/Proteomic Profiles in CALERIE$346,973
R01 · FY2008 · AG · contact PI
Caloric Restriction Biomarkers Predict Type II Diabetes?$499,439
R01 · FY2007 · AG · contact PI
Macronutrients, Mitochondria and Blood Metabolome/Proteome Disease Risk Profiles$457,626
U01 · FY2007 · ES · contact PI
Serum Metabolomic/Proteomic Profiles in CALERIE$357,333
R01 · FY2007 · AG · contact PI
Caloric Restriction Biomarkers Predict Type II Diabetes?$557,342
R01 · FY2006 · AG · contact PI
Nutrition Modulated Metabolism as a Disease Risk Factor$543,074
R01 · FY2006 · CA · contact PI
Serum Metabolomic/Proteomic Profiles in CALERIE$378,243
R01 · FY2006 · AG · contact PI
Nutrition Modulated Metabolism as a Disease Risk Factor$47,423
R01 · FY2006 · CA · contact PI
Nutrition Modulated Metabolism as a Disease Risk Factor$574,658
R01 · FY2005 · CA
Caloric Restriction Biomarkers Predict Type II Diabetes?$506,601
R01 · FY2005 · AG
Biomarkers of Aging in the Sera Metabolome$151,571
R21 · FY2005 · AG
Biomarkers of Aging in the Sera Metabolome$151,571
R21 · FY2004 · AG
KGDHC and Mitochondrial Energetics$0
P01 · FY2002 · AG
DIETARY RESTRICTION SERUM MARKERS PREDICT HUMAN DISEASE$279,166
R01 · FY2001 · AG
KGDHC and Mitochondrial Energetics$0
P01 · FY2001 · AG
DIETARY RESTRICTION SERUM MARKERS PREDICT HUMAN DISEASE$272,386
R01 · FY2000 · AG
KGDHC and Mitochondrial Energetics$181,206
P01 · FY2000 · AG